Related Experiment Video
Updated: Jul 1, 2025
08:42
Using Multi-fluorinated Bile Acids and In Vivo Magnetic Resonance Imaging to Measure Bile Acid Transport
Published on: November 27, 2016
11.2K
3α-Hydroxybufadienolides in Bufo gallbladders: structural insights and biotransformation
Li-Jun Ruan1,2, Zhi-Jun Song2, Ren-Wang Jiang3
1State Key Laboratory of Bioactive Molecules and Draggability Assessment, College of Pharmacy, Jinan University, Guangzhou, 510632, China.
Natural Products and Bioprospecting
|March 4, 2024
Summary
Researchers identified 21 bufadienolides, including new compounds, from toad gallbladders. They discovered a key biotransformation process in toads, converting 3β-OH to 3α-OH bufadienolides for self-detoxification.
Area of Science:
- Natural Products Chemistry
- Pharmacology
- Toxicology
Background:
- Bufadienolides are naturally occurring steroids found in toads with significant pharmacological and ecological relevance.
- Bufadienolides exhibit diverse structural configurations, notably 3α-OH and 3β-OH isomers, with distinct biological occurrences and properties.
- Understanding bufadienolide biotransformation is crucial for elucidating their ecological roles and potential medicinal applications.
Purpose of the Study:
- To isolate and identify bufadienolides from the gallbladders of Bufo gargarizans.
- To investigate the biotransformation pathways of 3β-OH and 3α-OH bufadienolides in toad liver and kidney tissues.
- To explore the ecological and potential medical significance of bufadienolide structural diversity and metabolism.
Main Methods:
- Isolation and structural elucidation of bufadienolides using chromatographic and spectroscopic techniques.
- Analysis of bufadienolide configurations in toad bile and venom.
- In vitro biotransformation assays using toad liver and kidney tissue homogenates.
Main Results:
- Twenty-one bufadienolides were isolated, including four novel compounds and 17 known analogues.
- A significant predominance of 3α-OH bufadienolides was observed in toad bile, contrasting with the 3β-OH forms in toad venom.
- An irreversible biotransformation of 3β-OH to 3α-OH bufadienolides was confirmed in toad liver and kidney tissues.
Conclusions:
- The study reveals the structural diversity of bufadienolides in Bufo gargarizans.
- The findings suggest a critical role for the 3β-OH to 3α-OH conversion in toad self-detoxification mechanisms.
- This research enhances understanding of bufadienolide metabolism, contributing to their medical and ecological significance.
Related Concept Videos
01:16Drug Biotransformation: Overview
2.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.4K
01:16Hepatic Drug Excretion: Influencing Factors
129
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
129
01:17Hepatic Drug Excretion: Enterohepatic Cycling
1.5K
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
1.5K
01:14Drug Metabolism: Phase II Reactions
3.8K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.8K
01:24Phase II Reactions: Glucuronidation
420
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
420
01:23Drug Elimination: Non-Renal Routes
2.3K
The liver plays a pivotal role in eliminating drugs and their metabolites, primarily through a process known as biliary excretion. This process involves the hepatocytes, the primary cells in the liver that generate bile. A range of transporters actively expels polar drugs or hydrophilic drug metabolites into the bile, which transports the drugs and metabolites into the small intestine. From here, they are eventually expelled from the body through feces. In some instances, the original drug or a...
2.3K